| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ZBAOZhibao Technology Inc. Class A Ordinary Shares | 16.02M | 0.97 | 16.74 | 28.86% | 8.3% | 42.39% | 0.47 | |
| WDHWaterdrop Inc. | 503.83M | 1.79 | 0.18 | 5.36% | 14.98% | 8.92% | 43.43% | 0.05 |
| YBYuanbao Inc. American Depositary Shares | 658.52M | 20.33 | 0.18 | 60.6% | 23.34% | 100% | ||
| HUIZHuize Holding Limited | 19.48M | 2.27 | -1.77 | 4.46% | 1.35% | 4.21% | 0.21 | |
| TIRXTian Ruixiang Holdings Ltd | 12.13M | 0.46 | -3.87 | 158.74% | -11.06% | -12.03% | 7.4% | 0.03 |
| Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.53M | 3.09M | 2M | 3.25M | 2.79M | 1.35M | 1.24M | 3.22M |
| Revenue Growth % | - | 1.02% | -0.35% | 0.62% | -0.14% | -0.52% | -0.08% | 1.59% |
| Medical Costs & Claims | 137.05K | 0 | 651.49K | 743.06K | 948.9K | 2.69M | 460.79K | 1.7M |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - |
| Gross Profit | 1.39M | 3.09M | 1.35M | 2.51M | 1.84M | -1.34M | 783.46K | 1.52M |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 1.21% | -0.56% | 0.86% | -0.27% | -1.73% | 1.58% | 0.94% |
| Operating Expenses | 278.36K | 1.63M | 1.25M | 2.69M | 5.04M | 3.73M | 3.8M | 6.16M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 10.94K | 30.3K | 34.71K | 227.54K | 255.11K | 208.27K | 79.76K | 168.7K |
| Combined Ratio % | - | - | - | - | - | - | - | - |
| Operating Income | 1.12M | 1.46M | 102.67K | 560.14K | -2.25M | -5.07M | -3.02M | -4.65M |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | 0.31% | -0.93% | 4.46% | -5.02% | -1.25% | 0.4% | -0.54% |
| EBITDA | 1.13M | 1.49M | 137.38K | 787.68K | -2M | -4.86M | -2.94M | -4.48M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| Interest Expense | 0 | 22.89K | 18.83K | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | -15.76K | -50.3K | -330.16K | 0 | 0 | -123.65K | 0 | -1.68M |
| Pretax Income | 1.13M | 1.49M | 414K | 760.15K | -1.92M | -4.66M | -2.29M | -3.94M |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 168.25K | 365.19K | 238.21K | 126.06K | 24.53K | 23.64K | 161.34K | 42.12K |
| Effective Tax Rate % | - | - | - | - | - | - | - | - |
| Net Income | 963.32K | 1.12M | 175.79K | 634.1K | -1.94M | -4.68M | -2.45M | -3.99M |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | 0.16% | -0.84% | 2.61% | -4.07% | -1.41% | 0.48% | -0.62% |
| EPS (Diluted) | 0.24 | 0.28 | 0.04 | 0.10 | -0.28 | -0.45 | -0.19 | -0.12 |
| EPS Growth % | - | 0.16% | -0.84% | 1.25% | -3.83% | -0.61% | 0.58% | 0.37% |
| EPS (Basic) | 0.24 | 0.28 | 0.04 | 0.16 | -0.28 | -0.45 | -0.19 | -0.12 |
| Diluted Shares Outstanding | 4M | 4M | 4M | 6.4M | 6.89M | 10.37M | 12.67M | 32.93M |
| Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 988.81K | 8.74M | 8.41M | 10.06M | 40.35M | 35.03M | 35.48M | 39.98M |
| Asset Growth % | - | 7.84% | -0.04% | 0.2% | 3.01% | -0.13% | 0.01% | 0.13% |
| Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 26.18M | 26.8M | 28.09M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 26.18M | 26.8M | 28.09M |
| Total Current Assets | 678.37K | 8.45M | 8.09M | 9.56M | 31.63M | 34.86M | 27.62M | 39.92M |
| Cash & Equivalents | 96.1K | 6.71M | 6.24M | 6.14M | 30.02M | 2.51K | 2.38K | 297.29K |
| Receivables | 385.64K | 707.39K | 173.06K | 1000K | 320.85K | 1000K | 18.96K | 1000K |
| Other Current Assets | 166.48K | 947.72K | 1.25M | 1.72M | 937.05K | 861.69K | 800.2K | 785.1K |
| Goodwill & Intangibles | 40.38K | 16.68K | 170.35K | 160.22K | 147.54K | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 40.38K | 16.68K | 170.35K | 160.22K | 147.54K | 0 | 0 | 0 |
| PP&E (Net) | 15.92K | 17.35K | 144.56K | 332.24K | 771.49K | 152.13K | 61.15K | 57.8K |
| Other Assets | 254.14K | 254.28K | 6.57K | 7.42K | 7.8M | 20.08K | 7.8M | 0 |
| Total Liabilities | 270.37K | 1.27M | 830.73K | 1.42M | 1.36M | 1.55M | 3.06M | 6.09M |
| Total Debt | 0 | 373.38K | 117.71K | 321.93K | 660.97K | 145.52K | 57.4K | 1.18M |
| Net Debt | -96.1K | -6.34M | -6.13M | -5.82M | -29.36M | 143.01K | 55.02K | 881.31K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140.49K |
| Short-Term Debt | 0 | 373.38K | 0 | 0 | 0 | 0 | 0 | 983.42K |
| Total Current Liabilities | 270.37K | 1.27M | 790.61K | 1.29M | 1.12M | 1.49M | 3.06M | 5.92M |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.7M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 718.44K | 7.47M | 7.58M | 8.64M | 38.99M | 33.48M | 32.42M | 33.89M |
| Equity Growth % | - | 9.4% | 0.01% | 0.14% | 3.51% | -0.14% | -0.03% | 0.05% |
| Shareholders Equity | 718.44K | 7.47M | 7.58M | 8.64M | 38.99M | 33.48M | 32.42M | 33.89M |
| Minority Interest | 0 | 478 | 474 | 495 | 489 | 400 | 394 | 402 |
| Retained Earnings | -877.18K | 215.05K | 301.25K | 884.08K | -1.09M | -5.8M | -8.3M | -12.33M |
| Common Stock | 10K | 5K | 5K | 5K | 11.35K | 13.89K | 18.12K | 59.61K |
| Accumulated OCI | 130.84K | -438.46K | -419.3K | 52.67K | 296.36K | -3.39M | -3.41M | -2.6M |
| Return on Equity (ROE) | 1.34% | 0.27% | 0.02% | 0.08% | -0.08% | -0.13% | -0.07% | -0.12% |
| Return on Assets (ROA) | 0.97% | 0.23% | 0.02% | 0.07% | -0.08% | -0.12% | -0.07% | -0.11% |
| Equity / Assets | - | - | - | - | - | - | - | - |
| Debt / Equity | - | 0.05x | 0.02x | 0.04x | 0.02x | 0.00x | 0.00x | 0.03x |
| Book Value per Share | 0.18 | 1.87 | 1.89 | 1.35 | 5.66 | 3.23 | 2.56 | 1.03 |
| Tangible BV per Share | - | - | - | - | - | - | - | - |
| Oct 2017 | Oct 2018 | Oct 2019 | Oct 2020 | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 498.83K | 1.37M | 229.05K | -48.17K | -1.36M | -198.76K | 994.3K | 897.89K |
| Operating CF Growth % | - | 1.76% | -0.83% | -1.21% | -27.32% | 0.85% | 6% | -0.1% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - |
| Net Income | 963.32K | 1.12M | 175.79K | 634.1K | -1.94M | -4.68M | -2.45M | -3.99M |
| Depreciation & Amortization | 10.94K | 30.3K | 34.71K | 227.54K | 255.11K | 208.27K | 79.76K | 168.7K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 2.89M | 1.45M | 2.82M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.13K | 31 | 0 | 0 | 696 | 123.65K | 8.18K | 1.68M |
| Working Capital Changes | -473.31K | 222.78K | 18.55K | -909.81K | 324.83K | 1.26M | 1.91M | 220.25K |
| Cash from Investing | -258.08K | -9.62K | 37.01K | -3.46K | -7.5M | -28.9M | -992.72K | -1.82M |
| Capital Expenditures | -41.34K | -9.62K | -12.01K | -3.46K | -3.41K | -2.35K | 0 | 0 |
| Acquisitions | -216.74K | 0 | 0 | 0 | 0 | 0 | 0 | 77.89K |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | -29.01M | -27.78M | -28.14M |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 116.66K | 1000K | 1000K |
| Other Investing | 0 | 0 | 49.02K | 0 | -7.5M | 0 | -300K | -1.36M |
| Cash from Financing | 0 | 6.49M | -871.32K | -478.25K | 32.64M | 0 | -283 | 1.19M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 0 | 6.09M | -493.44K | -366.08K | 36.86M | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | 396.55K | -377.88K | -112.16K | -378.21K | 0 | -283 | 1000K |
| Other Financing | 0 | 6.09M | -493.44K | 0 | -3.84M | 0 | 0 | 0 |
| Net Change in Cash | 243.76K | 7.38M | -660.85K | -43.09K | 23.92M | -30.15M | -167 | 301.16K |
| Exchange Rate Effect | 3.01K | -471.03K | -55.59K | 486.78K | 145.01K | -1000K | -1.47K | 35.53K |
| Cash at Beginning | 3.19K | 246.95K | 7.63M | 6.97M | 6.92M | 30.84M | 695.24K | 695.08K |
| Cash at End | 246.95K | 7.63M | 6.97M | 6.92M | 30.84M | 695.24K | 695.08K | 996.24K |
| Free Cash Flow | 457.49K | 1.36M | 33.93K | -51.63K | -1.37M | -201.11K | 994.3K | 897.89K |
| FCF Growth % | - | 1.98% | -0.98% | -2.52% | -25.49% | 0.85% | 5.94% | -0.1% |
| FCF Margin % | - | - | - | - | - | - | - | - |
| FCF per Share | 0.11 | 0.34 | 0.01 | -0.01 | -0.2 | -0.02 | 0.08 | 0.03 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 27.13% | 52.74% | 94.87% | 105.63% | 214.77% | 474.94% | 342.42% | 244.29% |
| Medical Cost Ratio | 8.95% | 0% | 32.54% | 22.87% | 34% | 199.11% | 37.03% | 52.85% |
| Return on Equity (ROE) | 134.09% | 27.38% | 2.34% | 7.82% | -8.16% | -12.93% | -7.45% | -12.03% |
| Return on Assets (ROA) | 97.42% | 23.05% | 2.05% | 6.87% | -7.71% | -12.43% | -6.96% | -10.57% |
| Equity / Assets | 72.66% | 85.49% | 90.12% | 85.87% | 96.64% | 95.58% | 91.37% | 84.77% |
| Book Value / Share | 0.18 | 1.87 | 1.89 | 1.35 | 5.66 | 3.23 | 2.56 | 1.03 |
| Debt / Equity | - | 0.05x | 0.02x | 0.04x | 0.02x | 0.00x | 0.00x | 0.03x |
| Revenue Growth | - | 101.65% | -35.16% | 62.29% | -14.12% | -51.56% | -7.96% | 158.74% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Commissions | 2.68M | 1.32M | 1.24M | 3.22M |
| Commissions Growth | - | -50.49% | -6.07% | 158.74% |
| Risk management services | 115.01K | 27.25K | - | - |
| Risk management services Growth | - | -76.30% | - | - |
Tian Ruixiang Holdings Ltd (TIRX) grew revenue by 158.7% over the past year. This is strong growth.
Tian Ruixiang Holdings Ltd (TIRX) reported a net loss of $0.9M for fiscal year 2024.
Tian Ruixiang Holdings Ltd (TIRX) has a return on equity (ROE) of -12.0%. Negative ROE indicates the company is unprofitable.
Tian Ruixiang Holdings Ltd (TIRX) has a combined ratio of 244.3%. A ratio above 100% means claims and expenses exceed premiums.